-
Effect of silibinin on angiogenesis
Time of Update: 2020-04-03
Yoo Hg and others treated ECV304 cells with silybin, the results showed that the growth of endothelial cells was significantly inhibited, and a large number of cells apoptosis.
-
Heavyweight: 100 Xinyi provides 2019 ncov full set of antibodies - and is humanized
Time of Update: 2020-04-03
In order to achieve this method, four core materials and at least one germplasm control product are needed, i.e. antigen, gold standard detection antibody, c-line antibody and quality control positive antibody.
-
Chongqing University and enterprise research and development of super bacterial vaccine obtained clinical approval; humanwell pharmaceutical indirectly participated in research and development enterprises
Time of Update: 2020-04-03
The recombinant Staphylococcus aureus vaccine, developed by the Third Military Medical University and Chongqing Yuanlun Biotechnology Co., Ltd
jointly by the University
-
The University of Hong Kong has successfully developed a new influenza A vaccine
Time of Update: 2020-04-03
The research team has successfully developed a new type A influenza vaccine with attenuated vaccinia virus as the carrier.
-
What is the function of macrophages
Time of Update: 2020-04-03
By binding antigens to their specific molecular surfaces, macrophages ensure that other white blood cells do not mistake themselves for invaders.
-
Absorption and metabolism of taurine
Time of Update: 2020-04-03
There are four main metabolic pathways of taurine in the body: ① taurocholate is produced in the liver with choline, which is excreted into the digestive tract with bile to promote the digestion and absorption of fat and lipid substances.
-
What is pulmonary macrophage
Time of Update: 2020-04-03
The first step of pulmonary macrophages is to form monocytes in the bone marrow, another type of white blood cell.
-
Biorxiv: Chinese scientists reveal the potential T cell and B cell epitopes of 2019 ncov
Time of Update: 2020-02-26
The researchers identified 405 viral peptides with good antigen expression scores in human MHC-I and MHC-II alleles, and found two potential neutralizing B cell epitopes (440-460 and 494-506) near the receptor binding domain of 2019-ncov s protein.
-
Key points of novel coronavirus detection reagent registration technology review points issued by the drug administration
Time of Update: 2020-02-26
The antigen detection reagent shall provide a detailed method to determine the virus titer, and at the same time, it shall describe the confirmation method and verification results of virus samples in detail.
-
Allergy: electron microscopy helps to reveal the molecular mechanism of anaphylaxis
Time of Update: 2020-02-26
February 26, 2020 / BIOON / -- according to a recent study, scientists have revealed the molecular structure of IgE antibody, the key molecule of allergic diseases.
-
New coronavirus vaccine development! Evaluation of the combination of s-trimer candidate vaccine and pandemic vaccine adjuvant system by clover and GlaxoSmithKline
Time of Update: 2020-02-25
Clover biopharmaceutical is a global biopharmaceutical company in the clinical trial stage, which is committed to the R & D and industrialization of innovative drugs, high-end biological similar drugs and recombinant RNA virus trimer vaccine.
-
Ten big new drugs are coming! Roche gathers "three generals" to welcome the help of medicine o
Time of Update: 2020-02-23
Like a raging fire in the field of innovation and development in China, adorable drugs have been developed for ten years, especially since the 2015 drug review and approval reform
-
A well-known pharmaceutical company is expected to spend $1 billion in this field
Time of Update: 2020-02-21
[pharmaceutical network enterprise news] it is reported that GSK is cooperating with the biopharmaceutical company imaging biotechnology GmbH to develop a new type of adoptive cell therapy for various tumor indications.
-
SCI adv: light regulated car-t therapy can effectively kill skin cancer
Time of Update: 2020-02-20
By programming car T cells to be activated by blue light, researchers can precisely control T cells to destroy mouse skin tumors without damaging healthy tissues.
-
Light regulated car-t therapy can effectively kill skin cancer
Time of Update: 2020-02-20
By programming car T cells to be activated by blue light, researchers can precisely control T cells to destroy mouse skin tumors without damaging healthy tissues.
-
R & D strategy and early R & D pipeline of Genentech
Time of Update: 2020-02-20
Source: reference [1] Genentech's early oncology research and development pipeline uses a variety of technology platforms, from traditional small molecule drugs to bispecific antibodies, personalized mRNA tumor vaccines, personalized T-cell therapy, to develop innovative therapies for the benefit of patients.
-
17 new crown vaccine projects of 22 institutions are under development. Who will be the antidote to the epidemic
Time of Update: 2020-02-19
Some enterprises and institutions that are developing new coronavirus vaccine, and some vaccine products that have made rapid progress in arterial network sorting, have entered the stage of animal experiment.
-
Who will be the antidote to the epidemic
Time of Update: 2020-02-19
Therefore, the research and development of recombinant antigen protein vaccine is progressing smoothly, and the relevant achievements of Yan Jinghua's research team have entered the stage of animal experiment.
-
Chem. SCI.: three functional platform for building modular antibody fragments for 18f-pet or NIRF imaging
Time of Update: 2020-02-18
Positron emission computed tomography (PET) is a clinical imaging technique for understanding the biology of disease and promoting diagnosis and treatment; NIRF ）Imaging makes
-
$617 million! Which field will Frazier's new life science fund look forward
Time of Update: 2020-02-17
It is believed that the $617 million life science fund will give them more impetus to do more, and more companies can develop new therapies with their help.
